4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-264041
Options or other derivatives
- Director acquired 1,721 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-06-05 | Grant or award · Restricted Stock Units | +1,721 | 1,721 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…